重组人钙调素的制备及其对细胞增殖作用影响的研究

用PCR方法获得人钙调素基因Ⅲ(hCaMⅢcDNA),将其插入表达载体pBV220,构建重组表达质粒hCaMⅢ/pBV220,阳性重组子在大肠杆菌DH5α中经温度诱导可高效表达CaM蛋白,经15%SDS-PAGE分析,可观察到一分子量与理论值相符(约17kD)的诱导表达条带.进一步分析表达产物的性质表明,CaM主要以可溶性形式表达.Westernblot结果证实,17kD的表达条带可与标准鼠抗CaMMcAb起特异反应.用Phenyl-SepharoseCL-4B疏水亲和层析法纯化重组菌超声上清表达产物,可获得纯度达95%以上的CaM,每1L菌液可获CaM纯品3～4mg.生物活性测定结果提示,rhCaM具有与标准人脑CaM(Sigma)同样的激活NAD激酶的活性.将K562细胞及SP2/0细胞分别接种于24孔或96孔培养板,加入不同浓度rhCaM、CaM拮抗剂三氟拉嗪(TFP),培养48h后,用MTI比色法检测细胞增殖状况.rhCaM在一定浓度范围内与细胞增殖率成显著正相关;CaM拮抗剂TFP可抑制细胞增殖.将rhCaM加入已受TFP抑制的细胞,可恢复正常的细胞增殖功能.     

外源钙调素对粟酒裂殖酵母细胞增殖的影响

外源钙调素（ＣａＭ）对粟酒裂殖酵母（Ｓｃｈｉｚｏｓａｃｃｈａｒｏｍｙｃｅｓ ｐｏｍｂｅ）细胞增殖的影响。实验结果表明外源ＣａＭ能明显抑制粟酒裂殖酵母细胞的增殖,其作用方式是延长了粟酒裂殖酵母细胞生长的延滞期,抗粟酒裂殖酵母ＣａＭ抗体,ＴＦＰ及Ｐｈｅｎｙｌ－ＳｅｐｈａｒｏｓｅＣＬ－４Ｂ能降低ＣａＭ对细胞生长的抑制作用,而Ｃａ＾２＋及Ｃａ＾２＋螯合剂ＥＧＴＡ对ＣａＭ的抑制作用均无影响。以上结果提示,外     

外源钙调素对粟酒裂殖酵母细胞增殖的影响

外源钙调素（CaM）对粟酒裂殖酵母（Schizosaccharomycespombe）细胞增殖的影响。实验结果表明外源CaM能明显抑制粟酒裂殖酵母细胞的增殖,其作用方式是延长了粟酒裂殖酵母细胞生长的延滞期。抗粟酒裂殖酵母CaM抗体、TFP及Phenyl-SepharoseCL－4B能降低CaM对细胞生长的抑制作用,而Ca2+及Ca2+螫合剂EGTA对CaM的抑制作用均无影响。以上结果提示,外源CaM对粟酒裂殖酵母细胞增殖的抑制作用可能是由于胞外CaM激活了细胞膜上的Ca2+泵,使胞内Ca2+浓度降低所致。     

钙调素拮抗剂对人肺癌细胞增殖抑制及与cAMP信号系统相关性之初探

对钙调素（ＣａＭ）拮抗剂－三氟拉嗪在人肺癌细胞ＰＬＡ８０１的增殖抑制中的作用和ＣａＭ与ｃＡＭＰ信号系统水平的变化进行了研究,用５、１０、１５和２０μｍｏｌ／ＬＴＦＰ处理人肺癌细胞时观察到的ＴＦＰ在抑制细胞内ＣａＭ活性的同时,抑制了细胞的增殖,药物处理的细胞在软琼脂中形成的集落数减少且明显小于对照组细胞,使用流式细胞光度术分析细胞周期的结果表明：１０μｍｏｌ／ＬＴＦＰ处理抑制了Ｇ１期细胞的向Ｓ期折转     

钙调素参与拟南芥根细胞增殖及幼苗对外源脱落酸的敏感性反应过程

钙调素作为真核细胞的重要信号蛋白,在真核生物正常及逆境条件下的生长发育中发挥着重要作用.研究报道钙调素可促进离体培养的高等动植物细胞的增殖,但有关钙调素蛋白在植物体内的细胞增殖功能尚未见报道.特别是拟南芥基因组中存在7个编码经典钙调素亚型的基因,多数编码基因的功能有待进一步探究.首先借助常用的钙调素拮抗剂W7进行药理学实验,结果表明,野生型拟南芥幼苗根的生长受到了明显的抑制,根尖分生区的面积变小、细胞数目明显减少,根尖分生区中细胞分裂标记基因CYCB1;1的表达受到了明显抑制,这表明在根尖分生区W7可能通过对活性钙调素的抑制作用影响了根尖分生区域的细胞增殖,而根尖分生区正常的细胞增殖需要一定量活性钙调素蛋白的存在.脱落酸(ABA)是植物逆境下的重要激素,在植物种子萌发及幼苗生长发育中发挥着重要作用,W7存在下的拟南芥幼苗对ABA的敏感性下降.借助反向遗传学手段获得了拟南芥中三个编码典型钙调素蛋白基因的三重缺失突变体cam234,蛋白质印迹结果表明三重缺失突变体中钙调素蛋白的含量明显降低.相同培养条件下与野生型相比,三重突变体幼苗根长变短,并且幼苗对ABA敏感性也表现下降趋势,暗示着这三个基因编码的钙调素蛋白可能参与了根分生区域细胞增殖过程及幼苗对脱落酸的敏感性反应,讨论了钙调素的细胞增殖功能及与幼苗对脱落酸的敏感性反应间的关系.     

重组人乳铁蛋白对食管癌细胞体外增殖的影响

目的:研究重组人乳铁蛋白(rhLF)对体外培养的食管癌细胞的生长特性的影响.方法:MTT法评定rhLF对人食管癌细胞Eca-109、人肝脏细胞L0-2、CHO中国昌鼠细胞系的生长抑制作用.结果:重组人乳铁蛋白对人食管癌细胞系Eca-109的增殖有抑制作用并呈现剂量依赖性,对正常细胞无抑制作用.结论:重组人乳铁蛋白作为新的抗肿瘤化学治疗荆,可以抑制食管癌细胞Eca-109的增殖.     

钙调素拮抗剂的研究动态

从钙、钙调素的功能论及钙桔抗剂和钙调素拮抗剂的概念.并着重叙述了国内外钙调素拮抗剂研究中的问题和开发动态。     

钙调素拮抗剂对人肺癌细胞增殖抑制及与cAMP信号系统相关性之初探

对钙调素（ＣａＭ）拮抗剂—三氟拉嗪（ｔｒｉｆｌｕｏｐｅｒａｚｉｎｅ,ＴＦＰ）在人肺癌细胞ＰＬＡ８０１的增殖抑制中的作用和ＣａＭ与ｃＡＭＰ信号系统水平的变化进行了研究．用５、１０、１５和２０μｍｏｌ／ＬＴＦＰ处理人肺癌细胞时观察到ＴＦＰ在抑制细胞内ＣａＭ活性的同时,抑制了细胞的增殖．药物处理的细胞在软琼脂中形成的集落数减少且明显小于对照组细胞．使用流式细胞光度术分析细胞周期的结果表明：１０μｍｏｌ／ＬＴＦＰ处理抑制了Ｇ１期细胞向Ｓ期的转移．当用１０μｍｏｌ／ＬＴＦＰ作用细胞５ｍｉｎ时,细胞内ｃＡＭＰ水平达到正常水平的１．８倍,直到３ｈ仍明显高于正常水平．同时,ｃＡＭＰ依赖的ＰＫＡ的活性在加药后１５ｍｉｎ上升到正常水平的２．８倍,直到加药３ｈ．活性仍保持较高水平,结果表明：钙调素功能的抑制,提高了ＰＬＡ－８０１细胞内ｃＡＭＰ系统的水平,Ｃａ２＋－ＣａＭ和ｃＡＭＰ－ＰＫＡ两个信号系统的协调作用,抑制了细胞的增殖     

重组人血小板生成素对巨核细胞系-Dami细胞增殖的影响

为了探讨重组人血小板生成素（ｒｅｃｏｍ ｂｉｎａｎｔｈｕｍ ａｎ ｔｈｒｏｍ ｂｏｐｏｉｅｔｉｎ,简称ｒｈＴＰＯ）的生物学活性,采用了血浆凝块培养法,５－溴－２′－脱氧尿核苷（５－ＢｒｄＵ）掺入Ｄａｍ ｉ细胞ＤＮＡ－酶联免疫吸附法,研究了ｒｈＴＰＯ对巨核细胞系－Ｄａｍ ｉ细胞增殖的作用。结果发现, 在加有ｒｈＴＰＯ的培养基中, Ｄａｍ ｉ细胞迅速增殖, 集落数量和吸光度值高于对照组。实验组ｒｈＴＰＯ浓度为２５, ５０, １００, ２００ｎｇ／ｍ ｌ, Ｄａｍ ｉ细胞集落增殖率分别为２１．０５％ ,５７．８９％ ,１０５．２６％ ,１２１．０５％ ,吸光度增加率分别为１９．３５％ ,６１．２９％ ,１０３．２３％ ,１１９．３５％ ,ｒｈＴＰＯ促进Ｄａｍ ｉ细胞增殖的作用在一定范围内存在浓度依赖性。研究结果表明, ｒｈＴＰＯ对Ｄａｍ ｉ细胞具有促进增殖的作用。     

35S标记重组植物钙调素的制备方法

利用35S标记的氨基酸混合物喂养工程菌,成功地制备了35S标记的拟南芥钙调素亚型2(35S-ACaM2),对其纯度、放射活度、电泳行为及其灵敏性等进行了检测.结果表明从工程菌中制备的35S-ACaM2纯度高、放射活度高、Ca2+与EGTA存在时的电泳行为与未标记的ACaM2相同,可作为一种高灵敏性的探针用于检测钙调素结合蛋白.     

High-level soluble expression of recombinant human manganese superoxide dismutase in Escherichia coli, and its effects on proliferation of the leukemia cell

Manganese superoxide dismutase (Mn-SOD) is one of the major enzymes responsible for the defense against oxidative damage due to reactive oxygen species (ROS) in the mitochondria. The present study aimed to produce and evaluate the genetically engineered manganese superoxide dismutase protein. A recombinant plasmid containing DNA segment coding Mn-SOD protein was transformed into Escherichia coli (E. coli) Rosetta-gami strain, for expression. After induction with IPTG, an expected molecular mass of 25 kDa was detected by SDS-PAGE. After Ni-NTA affinity chromatography purification, the purity rate came up to 95%. UV spectroscopy data for our preparations indicated that a peak at 275 nm existed in the spectrum. SOD activity assay showed that the activity of the rhMn-SOD was 1890.9 U/mg. The ORAC level of rhMn-SOD was 151492.2 uM Trolox equiv/mg. Furthermore, in vitro bioactivity assay indicated that the rhMn-SOD protein can inhibit the proliferation of the leukemia K562 cells.     

重组人载脂蛋白AI米兰突变体在大肠杆菌中的高表达

用RT-PCR法从人肝总RNA库中克隆出人载脂蛋白Al的cDNA序列,再通过重叠PCR将载脂蛋白AI的第179位精氨酸密码子突变成半胱氨酸密码子,即载胎蛋白AI米兰突变体基因。将此目的基因克隆至表达载体pQE30,重组质粒转化JMl09宿主菌,经表达试验筛选出高表达克隆;工程菌经诱导后表达出含6个氨基酸前肽的载脂蛋白AI米兰突变体。表达产物主要以可溶形式存在,但也有部分为包涵体。     

High-level expression of complementary DNA encoding rat calmodulin in Escherichia coli

We report the production and characterization of a rat calmodulin made in Escherichia coli. To express the rat calmodulin cDNA in E. coli, we have employed an expression vector containing the E. coli trp promoter and trpA terminator. The cDNA was modified so as to delete the 5' nontranslated sequence and to incorporate a consensus sequence for the E. coli ribosome-binding site. Several codons for the N-terminal amino acids were selected to fit the E. coli consensus nucleotide sequence around the translational initiation codon. After induction of expression in E. coli, rat calmodulin accounted for over 30% of total cellular proteins. About 100 mg of recombinant rat calmodulin, purified to over 90% homogeneity by extraction from bacterial lysate followed by phenyl-Sepharose column chromatography, was obtained from 1 liter of E. coli culture. This recombinant calmodulin activated rat brain cyclic AMP phosphodiesterase to the same extent as the native calmodulin purified from rat brain. These results indicate that the overproduction system of the recombinant calmodulin in E. coli facilitates the study of the structure-function relationship by site-specific mutagenesis.     

High-level expression of human beta-defensin-2 gene with rare codons in E. coli cell-free system

Human beta-defensin-2 (hBD2) is A small cationic peptide with A broad range of antimicrobial activity. An E. coli cell-free system was employed to express the hBD2 fusion protein by using the hBD2 gene with 14 rare codons. The results showed that the expression level of trxA-hBD2 fusion protein was 0.35 mg/ml, which is the same as that obtained with A synthetic codon-optimized gene. By using another fusion partner (GFP), similar high-level expression was also achieved in this cell-free system. This meant that human beta-defensin-2 gene could be directly used to express hBD2 fusion protein efficiently in an E. coli cell-free system without the optimization of codons. The expression level of hBD2 fused with thioredoxin could be further improved up to 2.0 mg/ml by adopting A continuous exchange cell-free system. A simple one-stage affinity purification procedure was also developed to recover this fusion protein efficiently.     

Thialysine utilization by E. coli and its effects on cell growth

Summary Thialysine and selenalysine, two lysine isologs having the -methylene group substituted by a sulfur or a selenium atom, respectively, inhibit E. coli lysine-sensitive aspartokinase. The inhibition is specific, reversible and non-competitive. Compared to lysine, the two isologs have a less marked inhibitory effect, but show a similar homotropic cooperativity with a Hill's coefficient of about 2. The inhibition by each isolog is additive to that by lysine. Both compounds protect the enzyme against thermal inactivation. Overall, the data reported indicate that thialysine and selenalysine bind to the same allosteric site of lysine, the physiological modulator of the enzyme.     

High-level soluble expression of bioactive porcine myostatin propeptide in E. coli

Myostatin (MSTN) is a potent negative regulator of skeletal muscle mass. The activity of MSTN is suppressed by MSTN propeptide (MSTNPro), the N-terminal part of unprocessed MSTN that is cleaved off during posttranslational MSTN processing. Easy availability of MSTNPro would help to investigate the potential of the protein as an agent to enhance muscle growth in agricultural animal species. Thus, this study was designed to produce bioactive wild-type porcine MSTN propeptide (pMSTNProW) and its mutated form at the BMP-1/TLD proteolytic cleavage site (pMSTNProM) in Escherichia coli. The pMSTNProW and pMSTNProM genes were separately cloned into pMAL-c5X vector downstream of the maltose-binding protein (MBP) gene and were transformed and expressed in soluble forms in E. coli. For each milliliter of cell culture, about 40 μg of soluble MBP-pMSTNProW and MBP-pMSTNProM proteins were purified by amylose resin affinity chromatography. Further purification by anion exchange chromatography of the affinity-purified fractions yielded about 10 μg/mL culture of MBP-pMSTNProW and MBP-pMSTNProM proteins. Factor Xa protease cleaved the fusion partner MBP from MBP-pMSTNPro proteins, and approximately 4.2 μg of pMSTNProW and pMSTNProM proteins were purified per milliliter of culture. MBP-pMSTNProM was resistant to digestion by BMP-1 metalloproteinase, while MBP-pMSTNProW was cleaved into two fragments by BMP-1. Both MBP-pMSTNProW and MBP-pMSTNProM demonstrated their MSTN binding affinities in a pulldown assay. In an in vitro gene reporter assay, both proteins inhibited MSTN bioactivity without a significant difference in their inhibitory capacities, indicating that the cell culture-based gene reporter assay has limitation in detecting the true in vivo biological potencies of mutant forms of MSTNPro proteins at the BMP-1/TLD cleavage site. Current results show that a high-level production of bioactive porcine MSTNpro is possible in E. coli, and it remains to be investigated whether the administration of the MSTNpro can improve skeletal muscle growth in pigs via suppression of MSTN activity in vivo.     

High-level expression of human renin in Escherichia coli

The cDNA sequence for human renin was modified for use in the expression of the mature protein in E. coli. This was accomplished by the removal of the 5′ untranslated region and sequences coding for the signal peptide and a portion of the mature protein. An oligonucleotide linker was inserted which supplied the deleted coding information for the mature protein in a form optimized for translation in E. coli, in addition to an initiation codon. The modified gene was cloned into an expression vector consisting of the promoter from the tryptophan operon of E. coli and trp L Shine-Dalgarno sequence. In an appropriate host strain the expressed protein is the most prominent species present, and accounts for at least 10% of the total cellular protein. The expressed protein was verified to be renin by its molecular weight, ability to bind a renin antibody, and N-terminal amino acid sequence.     

细胞因子人MK基因的克隆及在大肠杆菌中的高效表达（简报）

For cloning the cytokine human Midkine (MK) gene, we designed by PCgene program and synthesized a pair of PCR specific primers according to the reported human MK cDNA sequence. Total cellular RNA was extracted from a human hepatoblastoma cell line HepG2, and then the target DNA fragment was obtained by RT-PCR and subcloned into plasmid pUC118. Checked with radioisotope sequencing and ABI 377A sequencer, the nucleotide sequence of the cloned MK cDNA was identical with the reported one. A prokaryotic expression vector, named pBV220, was used to express the MK protein efficiently in E. coli strain TG1 and a predicted band of 16.5 kD in Mr by 15% SDS-PAGE was found. The expressed recombinant protein was found in insoluble aggregated form and accounted for about 31.21% of the total cellular proteins. The first 15 N-terminal amino acid sequence analysis of this protein by Edman degradation method showed that it was accordant with that predicted from the cDNA sequence. The activity of neurite outgrowth-promoting of the MK crude samples was tested with brain cells isolated from 18-day embryos of SD rat.